Edition:
United Kingdom

Astrazeneca Pharma India says FDC Of XIGDUO XR Tablets Expected To Launch In India In Q4


Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Astrazeneca Pharma India Ltd ::FDC OF DAPAGLIFLOZIN + METFORMIN HYDROCHLORIDE FILM COATED TABLETS EXPECTED TO LAUNCH IN INDIA IN Q4 2017-18. 

Company Quote

1891.1
71.0 +3.90%
11:11am BST